Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
QULIPTA (AbbVie)
(https://qulipta.com) 📸 Data Snapshot: June 19, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE QULIPTA® (atogepant) for Migraine Prevention (https://qulipta.com)
QULIPTA® (atogepant) for Migraine Prevention
Discover QULIPTA® (atogepant), a pill specifically designed to prevent migraine attacks in adults. See full Patient and Safety Information.
NAV_HEADER_HEADING_REPEATED_BODY What Is QULIPTA® (atogepant)? – A Migraine Preventive Treatment (https://qulipta.com/why-qulipta/)
What Is QULIPTA® (atogepant)? – A Migraine Preventive Treatment
Learn about QULIPTA® (atogepant), a pill that can help prevent migraine attacks in adults and keep them away over time. See full Patient & Safety Info.
NAV_HEADER_HEADING_REPEATED_BODY Sign Up – QULIPTA® (atogepant) Complete Savings Program (https://qulipta.com/savings-support/qulipta-complete-savings-program/)
Sign Up – QULIPTA® (atogepant) Complete Savings Program
Enroll now to get savings and support from the QULIPTA™ Complete savings program. See full Patient and Safety Information.
NAV_HEADER_HEADING_REPEATED_BODY Sign up for QULIPTA® (atogepant) Savings and Support (https://qulipta.com/savings-support/qulipta-complete-savings-program/sign-up/)
Sign up for QULIPTA® (atogepant) Savings and Support
Access savings and get updates from QULIPTA® (atogepant). See full Patient and Safety Information.
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://qulipta.com) QULIPTA® (atogepant) for Migraine Prevention
FOR THE PREVENTIVE TREATMENT OF MIGRAINE IN ADULTS. Learn how AbbVie could help you save on QULIPTA®. Call 1-855-QULIPTA or click to learn more › MIGRAINE MODE [H1] MORE ZERO-MIGRAINEDAYS ARE POSSIBLE In 3-month studies, QULIPTA® helped significantly reduce monthly migraine days. [H2] THE FORGET-YOU-GET-MIGRAINE MEDICINE™ [IMG: Bottle of QULIPTA and a white round 60mg QULIPTA pill with A 60 lettering] Not actual size. You’ll never truly forget migraine, but QULIPTA is a once-daily pill that reduces migraine attacks to help give you that forget-you-get migraine feeling. DISCOVER QULIPTA [H2] The Results Are In: QULIPTA vs Topiramate A head-to-head study shows how QULIPTA stacked up against topiramate. SEE THE DATA WHAT ARE YOU CURRENTLY TAKING TO PREVENT MIGRAINE ATTACKS? I'm taking QULIPTA I'm taking a different prescription oral medication I'm using a prescription injectable medication I used to take a migraine preventive but don't anymore I treat migraine attacks as I get them I'm taking QULIPTA Learn how you can save on QULIPTA I'm taking a different prescription oral medication Learn how QULIPTA is the only pill of its kind approved to prevent migraine of any frequency I'm using a prescription injectable medication Learn how you can prevent migraine attacks with QULIPTA, a once-daily pill I used to take a migraine preventive but don't anymore Learn how QULIPTA is the only pill of its kind approved to prevent migraine of any frequency I treat migraine attacks as I get them Learn about QULIPTA, a pill specifically designed to prevent migraine attacks BACK TO OPTIONS Not actual card. [H2] SAVINGS & SUPPORT MADE SIMPLE To save on QULIPTA, activate the QULIPTA Savings Card and show it at the pharmacy when filling your prescription. SIGN UP NOW †Eligibility: Available to patients with commercial insurance coverage for QULIPTA® (atogepant) who meet eligibility criteria. This co-pay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs), or where prohibited by law. Offer subject to change or termination without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. For full Terms and Conditions, visit QULIPTASavingsCard.com. For additional information, call 1-855-QULIPTA (1-855-785-4782). To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy. [H2] READY TO TAKE THE NEXT STEP? It's time to talk about migraine with your doctor and ask whether QULIPTA is right for you. FIND A DOCTOR [H2] WANT TO LEARN MORE? Stay informed and get the latest information sent to your inbox. SIGN UP NOW [H3] “The moment I realized this was working for me was a huge relief.” Kelsi QULIPTA patient Kelsi was compensated to share her story. Changes in therapy status may have occurred since that time. Individual results may vary. In 3-month studies, QULIPTA® helped significantly reduce monthly migraine days. Individual results may vary. SEE PATIENT STORIES [H2] IMPORTANT SAFETY INFORMATION Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you: Have high blood pressure Have circulation problems in your fingers and toes Have kidney problems or are on dialysis Have liver problems Are pregnant or plan to become pregnant Are breastfeeding or plan to breastfeed Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Your healthcare provider may need to change the dose of QULIPTA when taken with certain other medicines. QULIPTA can cause serious side effects, including: Allergic (hypersensitivity) reactions, including anaphylaxis: Serious allergic reactions can happen when you take QULIPTA or days after. Stop taking QULIPTA and get emergency medical help right away if you get any of the following symptoms, which may be part of a serious allergic reaction: swelling of the face, lips, or tongue; itching; trouble breathing; hives; or rash. High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure. Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur. The most common side effects of QULIPTA are nausea, constipation, and fatigue/sleepiness. These are not all the possible side effects of QULIPTA. QULIPTA is available in 10 mg, 30 mg, and 60 mg tablets. What is QULIPTA® (atogepant)? QULIPTA is a prescription medicine used for the preventive treatment of migraine in adults. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more. US-QLP-250105 Please see full Patient Information. [H3] Transcript [H6] SPEAK WITH A DOCTOR ONLINE TO LEARN IF QULIPTA MAY BE RIGHT FOR YOU Talk to a doctor from the comfort of your home with convenient telemedicine appointments. Here's how: Answer a few simple questions about your migraine attacks and current treatment plan. Connect directly with a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript®. If a prescription is written, you can pick it up from your local pharmacy or have it sent straight to you with at-home delivery. By clicking “TALK WITH A DOCTOR NOW” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE. If you agree to the above, click “TALK WITH A DOCTOR NOW” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on QULIPTA.com. TALK WITH A DOCTOR NOW BACK TO SITE [H6] LEAVING ABBVIE WEB SITE You are leaving the QUILIPTA site and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of QUILIPTA.com or AbbVie. Do you wish to leave this site? NO YES [H2] Important Safety Information Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. [H2] Important Safety Information Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. [H2] Important Safety Information Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. [H2] Important Safety Information Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. [H2] IMPORTANT SAFETY INFORMATION Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you: Have high blood pressure Have circulation problems in your fingers and toes Have kidney problems or are on dialysis Have liver problems Are pregnant or plan to become pregnant Are breastfeeding or plan to breastfeed Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Your healthcare provider may need to change the dose of QULIPTA when taken with certain other medicines. QULIPTA can cause serious side effects, including: Allergic (hypersensitivity) reactions, including anaphylaxis: Serious allergic reactions can happen when you take QULIPTA or days after. Stop taking QULIPTA and get emergency medical help right away if you get any of the following symptoms, which may be part of a serious allergic reaction: swelling of the face, lips, or tongue; itching; trouble breathing; hives; or rash. High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure. Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur. The most common side effects of QULIPTA are nausea, constipation, and fatigue/sleepiness. These are not all the possible side effects of QULIPTA. QULIPTA is available in 10 mg, 30 mg, and 60 mg tablets. What is QULIPTA® (atogepant)? QULIPTA is a prescription medicine used for the preventive treatment of migraine in adults. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more. US-QLP-250105
SUB-PAGE (https://qulipta.com/why-qulipta/) What Is QULIPTA® (atogepant)? – A Migraine Preventive Treatment
FOR THE PREVENTIVE TREATMENT OF MIGRAINE IN ADULTS. Learn how AbbVie could help you save on QULIPTA®. Call 1-855-QULIPTA or click to learn more › MIGRAINE MODE [H1] WHY QULIPTA®? [H2] QULIPTA is the only pill of its kind that blocks CGRP and is approved to prevent migraine of any frequency CGRP is a protein believed to be a cause of migraine attacks Migraine attacks don't have to take over your daily routine. With QULIPTA, more zero-migraine days are possible. In 3-month studies, QULIPTA significantly reduced monthly migraine days. [H3] THE PREVENTIVE POWER OF QULIPTA QULIPTA is a once-daily pill that reduces migraine attacks, making more zero-migraine days possible GETS RIGHT TO WORK TO PREVENT MIGRAINE ATTACKS Not actual size. KEEPS MIGRAINE ATTACKS AWAY OVER TIME In 3-month studies, QULIPTA® significantly reduced monthly migraine days. Sign up for savings WHEN IS YOUR NEXT DOCTOR'S VISIT? Within 30 days Within 3 months Within 6 months I don't have one scheduled Within 30 days Learn how eligible patients can save on out-of-pocket costs for QULIPTA Within 3 months Our doctor discussion guide will help you get the migraine conversation started with your doctor Within 6 months Prepare for your appointment with our doctor discussion guide I don't have one scheduled Connect with a doctor from the comfort of your home with flexible telemedicine appointments BACK TO OPTIONS [H4] See what migraine prevention with QULIPTA looks like Once-daily pill Approved for episodic and chronic migraine More zero-migraine days possible In 3-month studies, QULIPTA significantly reduced monthly migraine days. Few side effects The most common side effects are nausea (QULIPTA 5-9% vs Placebo 3%), constipation (QULIPTA 6-8% vs Placebo 2%), and fatigue/sleepiness (QULIPTA 4-5% vs Placebo 4%). These are not all the possible side effects of QULIPTA. [H2] HOW DOES QULIPTA WORK WITHIN YOUR BODY? Your body has a protein called calcitonin gene-related peptide, or CGRP CGRP is believed to play a major role in migraine attacks causing pain and inflammation QULIPTA (atogepant) blocks CGRP While some medications used to prevent migraine were initially developed to treat other conditions, QULIPTA was specifically designed to prevent migraine attacks by directly targeting the CGRP receptor and blocking CGRP from binding. Talking with your healthcare provider can help you understand if QULIPTA is right for you. START THE CONVERSATION [H2] WANT TO LEARN MORE? Stay informed and get the latest information sent to your inbox. SIGN UP NOW [H2] TALK WITH A DOCTOR ONLINE Convenient telemedicine appointments are available CONNECT NOW [H2] SAVINGS & SUPPORT MADE SIMPLE To save on QULIPTA, activate the QULIPTA Complete Savings Card and show it at the pharmacy when filling your prescription SIGN UP NOW [H2] IMPORTANT SAFETY INFORMATION Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you: Have high blood pressure Have circulation problems in your fingers and toes Have kidney problems or are on dialysis Have liver problems Are pregnant or plan to become pregnant Are breastfeeding or plan to breastfeed Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Your healthcare provider may need to change the dose of QULIPTA when taken with certain other medicines. QULIPTA can cause serious side effects, including: Allergic (hypersensitivity) reactions, including anaphylaxis: Serious allergic reactions can happen when you take QULIPTA or days after. Stop taking QULIPTA and get emergency medical help right away if you get any of the following symptoms, which may be part of a serious allergic reaction: swelling of the face, lips, or tongue; itching; trouble breathing; hives; or rash. High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure. Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur. The most common side effects of QULIPTA are nausea, constipation, and fatigue/sleepiness. These are not all the possible side effects of QULIPTA. QULIPTA is available in 10 mg, 30 mg, and 60 mg tablets. What is QULIPTA® (atogepant)? QULIPTA is a prescription medicine used for the preventive treatment of migraine in adults. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more. US-QLP-250105 Please see full Patient Information. [H3] Transcript [H6] SPEAK WITH A DOCTOR ONLINE TO LEARN IF QULIPTA MAY BE RIGHT FOR YOU Talk to a doctor from the comfort of your home with convenient telemedicine appointments. Here's how: Answer a few simple questions about your migraine attacks and current treatment plan. Connect directly with a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript®. If a prescription is written, you can pick it up from your local pharmacy or have it sent straight to you with at-home delivery. By clicking “TALK WITH A DOCTOR NOW” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE. If you agree to the above, click “TALK WITH A DOCTOR NOW” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on QULIPTA.com. TALK WITH A DOCTOR NOW BACK TO SITE [H6] LEAVING ABBVIE WEB SITE You are leaving the QUILIPTA site and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of QUILIPTA.com or AbbVie. Do you wish to leave this site? NO YES [H2] Important Safety Information Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. [H2] Important Safety Information Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. [H2] Important Safety Information Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. [H2] Important Safety Information Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. [H2] IMPORTANT SAFETY INFORMATION Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you: Have high blood pressure Have circulation problems in your fingers and toes Have kidney problems or are on dialysis Have liver problems Are pregnant or plan to become pregnant Are breastfeeding or plan to breastfeed Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Your healthcare provider may need to change the dose of QULIPTA when taken with certain other medicines. QULIPTA can cause serious side effects, including: Allergic (hypersensitivity) reactions, including anaphylaxis: Serious allergic reactions can happen when you take QULIPTA or days after. Stop taking QULIPTA and get emergency medical help right away if you get any of the following symptoms, which may be part of a serious allergic reaction: swelling of the face, lips, or tongue; itching; trouble breathing; hives; or rash. High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure. Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur. The most common side effects of QULIPTA are nausea, constipation, and fatigue/sleepiness. These are not all the possible side effects of QULIPTA. QULIPTA is available in 10 mg, 30 mg, and 60 mg tablets. What is QULIPTA® (atogepant)? QULIPTA is a prescription medicine used for the preventive treatment of migraine in adults. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more. US-QLP-250105
SUB-PAGE (https://qulipta.com/savings-support/qulipta-complete-savings-program/) Sign Up – QULIPTA® (atogepant) Complete Savings Program
FOR THE PREVENTIVE TREATMENT OF MIGRAINE IN ADULTS. Learn how AbbVie could help you save on QULIPTA®. Call 1-855-QULIPTA or click to learn more › MIGRAINE MODE [H1] QULIPTA™ (atogepant) SUPPORT & SAVINGS Whether you’re already using QULIPTA™ (atogepant), or just looking to learn more about it, you’re just a few clicks away from QULIPTA resources and potential savings. To see how we can help , let’s learn a little more about you. [H1] QULIPTA™ (atogepant) SUPPORT & SAVINGS Whether you’re already using QULIPTA™ (atogepant), or just looking to learn more about it, you’re just a few clicks away from QULIPTA resources and potential savings. To see how we can help , let’s learn a little more about you. SAVINGS CARD for as little as $0 A Month BIN: XXXX PCN: XXXX GRP: XXXX ID#: XXXX LET’S GET YOU STARTED with savings & Support Take advantage of personalized support and savings with the QULIPTA Patient Savings Program. Fill out the information below and submit to enroll. Once enrolled, here’s what you can expect: quick, affordable access to Qulipta Eligible commercially insured patients pay as little as $0 a month. If you experience an insurance delay or denial, eligible patients can receive QULIPTA shipped directly to their door* quick, affordable access to Qulipta Eligible commercially insured patients pay as little as $0 a month. If you experience an insurance delay or denial, eligible patients can receive QULIPTA shipped directly to their door* quick, affordable access to Qulipta Eligible commercially insured patients pay as little as $0 a month. If you experience an insurance delay or denial, eligible patients can receive QULIPTA shipped directly to their door* Questions? Support is only a phone call away. Call 1-855-QULIPTA (1-855-XXXXX) Monday through Friday, 8AM-8PM ET *Terms and Conditions apply. This benefit covers QULIPTA. Eligibility: Available to patients with commercial prescription insurance coverage for QULIPTA who meet eligibility criteria. Copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the QULIPTA Patient Savings Program Card and patient must call QULIPTA at 1-800-QULIPTA and stop use of the copay card. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from QULIPTA Patient Savings Program, including the copay card, from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. [H1] EVERYONE IS ELIGIBLE FOR PERSONALIZED SUPPORT Enroll today to get support and resources to help you start and stay on track with your prescribed treatment plan. ENROLL NOW [H1] SAVINGS & SUPPORT MADE SIMPLE [H2] START AND STAY ON TRACK FOR AS LITTLE AS $0 WITH 3 EASY STEPS. Could QULIPTA be right for you? [H2] QULIPTA Complete is here for you–at no additional cost Talk with a live person to answer questions about enrolling, your prescription, or what to expect with QULIPTA Eligible, commercially insured patients may pay as little as $0* per fill with the QULIPTA Complete Savings Card Access tools and downloads that are made to help support you on your treatment journey. Enroll online in just a few minutes JOIN NOW Or text† QULIPTA to 785478 [H2] Start saving with your first fill at the pharmacy You may be able to start treatment right away with 2 free fills* of QULIPTA while your insurance company approves your prescription coverage. Plus, with the QULIPTA Complete Savings Card, eligible, commercially insured patients may pay as little as $0* for each refill. *For eligible, commercially insured patients only. Please see Terms and Conditions here. ACCESS SAVINGS SUPPORT [H2] When you have questions, connect with a live person With just one click, you can chat with or call a QULIPTA Complete specialist who will support you. We can help you enroll in the program, navigate insurance challenges, and answer questions about your medication. Monday–Friday, 8:00 am to 8:00 pm Eastern Time. Call 1-855-QULIPTA (1-855-785-4782) [H2] Resources that help you start and stay on track with your prescribed treatment plan Get the support you need when you need it. Explore tools and resources that help you throughout your preventive migraine treatment with QULIPTA. EXPLORE RESOURCES If you have additional questions, you can call 1-855-QULIPTA (1-855-785-4782). *PROGRAM TERMS AND CONDITIONS: 1. This offer is valid only for patients 18 years of age or older and is good for use only with a valid prescription for QULIPTA® (atogepant) tablets at the time the prescription is filled by the pharmacist and dispensed to the patient. 2. This offer is not valid for use by patients enrolled in Medicare, Medicaid, or other federal or state programs (including any state pharmaceutical assistance programs) or private indemnity or HMO insurance plans that reimburse you for the entire cost of your prescription drugs. If at any time, a participating patient begins receiving prescription drug coverage under any federal, state, or government-funded healthcare program, the patient will no longer be eligible for the QULIPTA Complete Savings Card and must cease participation. This offer is not valid for cash-paying patients. 3. Eligible commercially insured patients may pay as little as $0 per monthly prescription fill. Patient out-of-pocket expense will vary; check with your pharmacist for your co-pay discount. Restrictions, including monthly, quarterly, and/or annual maximums, may apply. 4. Subject to all other terms and conditions, a commercially insured patient whose plan covers QULIPTA may receive up to a maximum annual benefit of $7,000 per calendar year, solely for the patient’s benefit, when using the QULIPTA Complete Savings Card. Commercially-insured patients for whom coverage is not available because the insurer has not established a coverage review process may be eligible to receive up to 2 one-month fills at no charge for an FDA-approved indication. Under this program, once an insurer has established a review process for coverage requests, commercially insured patients may receive up to a maximum of 2 one-month fills at no charge for an FDA-approved indication while coverage is pending. 5. Patients may not seek reimbursement for value received from the QULIPTA Complete Savings Card from any third-party payers. 6. AbbVie reserves the right to rescind, revoke, or amend this offer without notice. 7. Offer good only in the USA, including Puerto Rico, at participating retail pharmacies. Patients residing in or receiving treatment in certain states may not be eligible to participate in this program. 8. Void if prohibited by law, taxed, or restricted. 9. This card is not transferable. The selling, purchasing, trading, or counterfeiting of this card is prohibited by law. 10. This card has no cash value and may not be used in combination with any other discount, coupon, rebate, free trial, or similar offer for the specified prescription. 11. This offer is not health insurance. 12. By redeeming this offer, you acknowledge that you are an eligible commercially-insured patient and that you understand and agree to comply with the above terms and conditions. For questions about the program, including savings on mail-order prescriptions, or to activate your card ID, please call 1-855-QULIPTA (1.855.785.4782). To learn about AbbVie’s privacy practices and your privacy choices, visit https://abbv.ie/corpprivacy. †Msg and data rates apply. Msg frequency depends on user. Reply HELP for help; reply STOP to cancel. Consent to texts not required to sign up for offer. To Pharmacists: For further information, please contact 1-800-761-5285. [H2] IMPORTANT SAFETY INFORMATION Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you: Have high blood pressure Have circulation problems in your fingers and toes Have kidney problems or are on dialysis Have liver problems Are pregnant or plan to become pregnant Are breastfeeding or plan to breastfeed Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Your healthcare provider may need to change the dose of QULIPTA when taken with certain other medicines. QULIPTA can cause serious side effects, including: Allergic (hypersensitivity) reactions, including anaphylaxis: Serious allergic reactions can happen when you take QULIPTA or days after. Stop taking QULIPTA and get emergency medical help right away if you get any of the following symptoms, which may be part of a serious allergic reaction: swelling of the face, lips, or tongue; itching; trouble breathing; hives; or rash. High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure. Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur. The most common side effects of QULIPTA are nausea, constipation, and fatigue/sleepiness. These are not all the possible side effects of QULIPTA. QULIPTA is available in 10 mg, 30 mg, and 60 mg tablets. What is QULIPTA® (atogepant)? QULIPTA is a prescription medicine used for the preventive treatment of migraine in adults. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more. US-QLP-250105 Please see full Patient Information. [H6] YOU ARE ABOUT TO LEAVE QULIPTA.COM By clicking “Yes” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE. If you agree to the above, click “YES” to proceed to the third-party website. If you do not agree to the above, click “NO” to remain on QULIPTA.com. Yes No [H3] Transcript [H6] SPEAK WITH A DOCTOR ONLINE TO LEARN IF QULIPTA MAY BE RIGHT FOR YOU Talk to a doctor from the comfort of your home with convenient telemedicine appointments. Here's how: Answer a few simple questions about your migraine attacks and current treatment plan. Connect directly with a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript®. If a prescription is written, you can pick it up from your local pharmacy or have it sent straight to you with at-home delivery. By clicking “TALK WITH A DOCTOR NOW” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE. If you agree to the above, click “TALK WITH A DOCTOR NOW” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on QULIPTA.com. TALK WITH A DOCTOR NOW BACK TO SITE [H6] LEAVING ABBVIE WEB SITE You are leaving the QUILIPTA site and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions a
SUB-PAGE (https://qulipta.com/savings-support/qulipta-complete-savings-program/sign-up/) Sign up for QULIPTA® (atogepant) Savings and Support
FOR THE PREVENTIVE TREATMENT OF MIGRAINE IN ADULTS. Learn how AbbVie could help you save on QULIPTA®. Call 1-855-QULIPTA or click to learn more › MIGRAINE MODE [H1] QULIPTA™ (atogepant) SUPPORT & SAVINGS Whether you’re already using QULIPTA™ (atogepant), or just looking to learn more about it, you’re just a few clicks away from QULIPTA resources and potential savings. To see how we can help , let’s learn a little more about you. [H1] QULIPTA™ (atogepant) SUPPORT & SAVINGS Whether you’re already using QULIPTA™ (atogepant), or just looking to learn more about it, you’re just a few clicks away from QULIPTA resources and potential savings. To see how we can help , let’s learn a little more about you. SAVINGS CARD for as little as $0 A Month BIN: XXXX PCN: XXXX GRP: XXXX ID#: XXXX LET’S GET YOU STARTED with savings & Support Take advantage of personalized support and savings with the QULIPTA Patient Savings Program. Fill out the information below and submit to enroll. Once enrolled, here’s what you can expect: quick, affordable access to Qulipta Eligible commercially insured patients pay as little as $0 a month. If you experience an insurance delay or denial, eligible patients can receive QULIPTA shipped directly to their door* quick, affordable access to Qulipta Eligible commercially insured patients pay as little as $0 a month. If you experience an insurance delay or denial, eligible patients can receive QULIPTA shipped directly to their door* quick, affordable access to Qulipta Eligible commercially insured patients pay as little as $0 a month. If you experience an insurance delay or denial, eligible patients can receive QULIPTA shipped directly to their door* Questions? Support is only a phone call away. Call 1-855-QULIPTA (1-855-XXXXX) Monday through Friday, 8AM-8PM ET *Terms and Conditions apply. This benefit covers QULIPTA. Eligibility: Available to patients with commercial prescription insurance coverage for QULIPTA who meet eligibility criteria. Copay assistance program is not available to patients receiving prescription reimbursement under any federal, state, or government-funded insurance programs (for example, Medicare [including Part D], Medicare Advantage, Medigap, Medicaid, TRICARE, Department of Defense, or Veterans Affairs programs) or where prohibited by law or by the patient’s health insurance provider. If at any time a patient begins receiving prescription drug coverage under any such federal, state, or government-funded healthcare program, patient will no longer be able to use the QULIPTA Patient Savings Program Card and patient must call QULIPTA at 1-800-QULIPTA and stop use of the copay card. Patients residing in or receiving treatment in certain states may not be eligible. Patients may not seek reimbursement for value received from QULIPTA Patient Savings Program, including the copay card, from any third-party payers. Offer subject to change or discontinuance without notice. Restrictions, including monthly maximums, may apply. This is not health insurance. [H1] ACTIVATE SAVINGS AND SUPPORT NOW [H4] Sign up to activate your savings card today. Show it at your pharmacy every time you refill your medication to save. Let’s go! Could QULIPTA be right for you? [H2] IMPORTANT SAFETY INFORMATION Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you: Have high blood pressure Have circulation problems in your fingers and toes Have kidney problems or are on dialysis Have liver problems Are pregnant or plan to become pregnant Are breastfeeding or plan to breastfeed Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Your healthcare provider may need to change the dose of QULIPTA when taken with certain other medicines. QULIPTA can cause serious side effects, including: Allergic (hypersensitivity) reactions, including anaphylaxis: Serious allergic reactions can happen when you take QULIPTA or days after. Stop taking QULIPTA and get emergency medical help right away if you get any of the following symptoms, which may be part of a serious allergic reaction: swelling of the face, lips, or tongue; itching; trouble breathing; hives; or rash. High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure. Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur. The most common side effects of QULIPTA are nausea, constipation, and fatigue/sleepiness. These are not all the possible side effects of QULIPTA. QULIPTA is available in 10 mg, 30 mg, and 60 mg tablets. What is QULIPTA® (atogepant)? QULIPTA is a prescription medicine used for the preventive treatment of migraine in adults. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more. US-QLP-250105 Please see full Patient Information. [H3] Transcript [H6] SPEAK WITH A DOCTOR ONLINE TO LEARN IF QULIPTA MAY BE RIGHT FOR YOU Talk to a doctor from the comfort of your home with convenient telemedicine appointments. Here's how: Answer a few simple questions about your migraine attacks and current treatment plan. Connect directly with a licensed healthcare provider or schedule an appointment at your convenience. A fee is charged by UpScript®. If a prescription is written, you can pick it up from your local pharmacy or have it sent straight to you with at-home delivery. By clicking “TALK WITH A DOCTOR NOW” below, you acknowledge and agree that AbbVie does not, in any way, endorse or recommend the qualifications of any physician associated with the third-party website, or the quality of medical care any of those physicians can provide. AbbVie makes no guarantees that using the third-party website will result in your desired outcome. It is wholly and solely your responsibility to assess the qualifications of a potential physician. AbbVie recommends that you meet and discuss the benefits and risks of all potential treatments with the potential physician. ABBVIE AND ITS RESPECTIVE AFFILIATES HEREBY DISCLAIM ANY LIABILITY ARISING FROM YOUR USE AND/OR RELIANCE ON THE INFORMATION CONTAINED ON THE THIRD-PARTY WEBSITE. If you agree to the above, click “TALK WITH A DOCTOR NOW” to proceed to the third-party website. If you do not agree to the above, click “BACK TO SITE” to remain on QULIPTA.com. TALK WITH A DOCTOR NOW BACK TO SITE [H6] LEAVING ABBVIE WEB SITE You are leaving the QUILIPTA site and connecting to a site that is not under the control of AbbVie. AbbVie is not responsible for the contents of any such site or any further links from such site. AbbVie is providing these links to you only as a convenience and the inclusion of any link does not imply the endorsement of the linked site by AbbVie. You should also be aware that the linked site may be governed by its own set of terms and conditions and privacy policy for which AbbVie has no responsibility. Conversely, the presence of this link does not imply the linked site's endorsement of QUILIPTA.com or AbbVie. Do you wish to leave this site? NO YES [H2] Important Safety Information Do not take QULIPTA® (atogepant) if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. [H2] Important Safety Information Do not take QULIPTA® (atogepant) if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. [H2] Important Safety Information Do not take QULIPTA® (atogepant) if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. [H2] Important Safety Information Do not take QULIPTA® (atogepant) if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. [H2] IMPORTANT SAFETY INFORMATION Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you: Have high blood pressure Have circulation problems in your fingers and toes Have kidney problems or are on dialysis Have liver problems Are pregnant or plan to become pregnant Are breastfeeding or plan to breastfeed Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Your healthcare provider may need to change the dose of QULIPTA when taken with certain other medicines. QULIPTA can cause serious side effects, including: Allergic (hypersensitivity) reactions, including anaphylaxis: Serious allergic reactions can happen when you take QULIPTA or days after. Stop taking QULIPTA and get emergency medical help right away if you get any of the following symptoms, which may be part of a serious allergic reaction: swelling of the face, lips, or tongue; itching; trouble breathing; hives; or rash. High blood pressure: New or worsening of high blood pressure can happen. Contact your healthcare provider if you have an increase in blood pressure. Raynaud’s phenomenon: A type of circulation problem can worsen or happen. Raynaud’s phenomenon can lead to your fingers or toes feeling numb, cool, or painful, or changing color from pale, to blue, to red. Contact your healthcare provider if these symptoms occur. The most common side effects of QULIPTA are nausea, constipation, and fatigue/sleepiness. These are not all the possible side effects of QULIPTA. QULIPTA is available in 10 mg, 30 mg, and 60 mg tablets. What is QULIPTA® (atogepant)? QULIPTA is a prescription medicine used for the preventive treatment of migraine in adults. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088. If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more. US-QLP-250105
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 2 |
| /why-qulipta/ | 0 | 2 |
| /savings-support/qulipta-complete-savings-program/ | 2 | 2 |
| /savings-support/qulipta-complete-savings-program/sign-up/ | 0 | 2 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage schema
[
{
"@context": "https://schema.org",
"@type": "MedicalWebPage",
"url": "https://www.qulipta.com/",
"name": "QULIPTA® (atogepant) for Migraine Prevention",
"description": "Discover QULIPTA® (atogepant), a pill specifically designed to prevent migraine attacks in adults. See full Patient and Safety Information.",
"audience": {
"@type": "MedicalAudience",
"audiencetype": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Migraine.",
"description": "Migraine is a neurological condition characterized by recurrent headaches that can be moderate to severe in intensity. Migraine headaches are often accompanied by other symptoms such as sensitivity to light, sound, or smells, nausea, and vomiting. Migraines can be triggered by various factors such as stress, certain foods, hormonal changes, and environmental factors."
}
},
"mainEntity": {
"@type": "Drug",
"name": "QULIPTA",
"description": "QULIPTA is a once-daily pill that blocks CGRP and is approved to prevent migraine of any frequency.",
"activeIngredient": "Atogepant.",
"sameAs": "https://en.wikipedia.org/wiki/Atogepant",
"warning": "QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you have kidney problems or are pregnant or plan to become pregnant.",
"manufacturer": {
"@type": "Organization",
"name": "AbbVie",
"brand": "QULIPTA",
"url": "https://www.abbvie.com",
"description": "AbbVie is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative medicines in various therapeutic areas, including immunology, oncology, neuroscience, and virology."
},
"prescribingInfo": "https://www.rxabbvie.com/pdf/qulipta_pil.pdf"
}
}
]
/why-qulipta/
[
{
"@context": "https://schema.org",
"@type": "MedicalWebPage",
"url": "https://www.qulipta.com/why-qulipta",
"name": "What Is QULIPTA® (atogepant)? - A Migraine Preventive Treatment",
"description": "Learn about QULIPTA® (atogepant), a pill that can help prevent migraine attacks in adults and keep them away over time. See full Patient & Safety Info.",
"audience": {
"@type": "MedicalAudience",
"audiencetype": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Migraine",
"description": "Migraine is a neurological condition characterized by intense, debilitating headaches."
}
},
"specialty": {
"@type": "MedicalSpecialty",
"@context": "https://schema.org",
"name": "Neurologic"
},
"mainEntity": {
"@context": "https://schema.org/",
"@type": "Drug",
"name": "QULIPTA",
"description": "QULIPTA is a once-daily pill that blocks CGRP and is approved to prevent migraine of any frequency.",
"activeIngredient": "Atogepant.",
"sameAs": "https://en.wikipedia.org/wiki/Atogepant",
"drugUnit": "mg",
"dosageForm": "Pill",
"mechanismOfAction": "QULIPTA (atogepant) is a calcitonin gene-related peptide (CGRP) receptor antagonist. It works by blocking the activity of CGRP, a protein that is involved in the development of migraines. By blocking CGRP, QULIPTA helps to prevent migraines from occurring.",
"warning": "Do not take QULIPTA if you have had an allergic reaction to atogepant or any ingredients in QULIPTA. QULIPTA may affect the way other medicines work, and other medicines may affect how QULIPTA works. Before taking QULIPTA, tell your healthcare provider about all your medical conditions, including if you have kidney problems or are on dialysis, or if you are pregnant or plan to become pregnant. Stop taking QULIPTA and get emergency medical help right away if you get any of the following symptoms, which may be part of a serious allergic reaction: swelling of the face, lips, or tongue; itching; trouble breathing; hives; or rash.",
"doseSchedule": {
"@type": "DoseSchedule",
"doseValue": [
"10",
"30",
"60"
],
"frequency": "Once daily",
"description": "Take one pill daily"
},
"drugClass": "Calcitonin gene-related peptide (CGRP) receptor antagonist.",
"manufacturer": {
"@type": "Organization",
"name": "AbbVie",
"brand": "QULIPTA",
"url": "https://www.abbvie.com",
"description": "AbbVie is a global biopharmaceutical company that focuses on discovering, developing, and delivering innovative medicines in various therapeutic areas, including immunology, oncology, neuroscience, and virology."
},
"prescribingInfo": "https://www.rxabbvie.com/pdf/qulipta_pil.pdf"
}
}
]
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
Based on 784 businesses audited.
Medical Devices, Pharma & Biotech BS: QULIPTA (AbbVie) (qulipta.com)
This site is a textbook example of high-substance pharmaceutical marketing: it utilizes trademarked emotional fluff in headings to capture attention but provides mandatory, forensic evidence in the body to satisfy regulators. It is low on bullshit because the cost of lying in this industry is legal catastrophe.
Convert emotional H2 headings like THE FORGET-YOU-GET-MIGRAINE MEDICINE into substance-led headings that cite the actual reduction in migraine days found in the trials. Replace generic CTAs like READY TO TAKE THE NEXT STEP with more specific technical paths like REVIEW THE CLINICAL TRIAL DATA. Provide a direct link to the ClinicalTrials.gov registration number instead of just internal PDFs to improve transparency. Reduce the three-fold repetition of the zero-migraine-day value prop across sub-pages to increase unique information density.
The site content perfectly aligns with the Medical and Pharma category, adhering to strict regulatory requirements for ‘Important Safety Information’ and clinical data presentation. The use of specific active ingredients like Atogepant and CGRP terminology confirms a high-fidelity industry match.
“The score of 23 is driven primarily by the Commodity Fingerprint and Information Density pillars. While the site is legally required to be factual, it relies heavily on trademarked slogans and generic pharmaceutical marketing templates. The high substance of the clinical data prevents the score from reaching a moderate or high BS level.”
This training module utilizes a snapshot of public data from QULIPTA (AbbVie), captured on June 19, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to QULIPTA (AbbVie): This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://qulipta.com to view the most current version of its content and learn from the source what this company is about and what it offers.